Claybrook Capital, LLC Abbott Laboratories Transaction History

Claybrook Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $182,432 - $222,464	-1,600 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$115.53 - $141.46 $184,848 - $226,336	1,600 New	1,600 $225,000
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $4.08 Million - $4.51 Million	-34,959 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$105.79 - $124.53 $3.7 Million - $4.35 Million	34,959 New	34,959 $4.05 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $3.88 Million - $4.69 Million	-58,549 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $3.73 Million - $4.23 Million	56,949 Added 3559.31%	58,549 $4.23 Million
Q1 2018 May 11, 2018	BUY	$56.27 - $63.62 $22,508 - $25,448	400 Added 33.33%	1,600 $96,000
Q4 2017 May 08, 2018	BUY	$53.68 - $57.47 $64,416 - $68,964	1,200	1,200 $68,000

3,189

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Claybrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Claybrook Capital, LLC with notifications on news.